Skip to content

About
Strategy
Portfolio
Team
Advisors
Partnerships
News
Contact
Investors

◀︎ All News

Pharma Two B Announces Licensing and Investment Agreement with Myung In Pharm

November 18th, 2021 by IBF

Categories Uncategorized

Israeli drug developer, Vensica Therapeutics, raises $16m in an investment round led by IBF

Pharma Two B Announces Positive Topline Results from its Pivotal Phase III Study of P2B001 in Early Parkinson’s Disease

© 2026 Israel Biotech Fund • Built with GeneratePress